My. Tsai et al., MOLECULAR AND BIOCHEMICAL APPROACHES IN THE IDENTIFICATION OF HETEROZYGOTES FOR HOMOCYSTINURIA, Atherosclerosis, 122(1), 1996, pp. 69-77
We compared biochemical and molecular methods for the identification o
f heterozygous carriers of mutations in the cystathionine beta-synthas
e (CBS) gene. Eleven relatives of seven unrelated patients with homocy
stinuria due to homozygous CBS deficiency and controls were studied wi
th respect to total homocysteine concentrations before and after methi
onine loading. In addition, we determined CBS activity in cultured ski
n fibroblasts and tested for the presence of five known mutations by a
PCR-based method in these seven patients, their relatives and control
s. The results demonstrate that measurement of homocysteine after meth
ionine loading and assay of CBS enzyme activity in cultured fibroblast
s identify most but not all heterozygotes. There was significant corre
lation between homocysteine concentrations and CBS activities only aft
er methionine loading (r = 0.12, 0.48, 0.48 and 0.50 at 0, 4, 6 and 8
h, respectively). Among the homozygous patients, molecular approaches
identified five T833C and two G(919)A mutations out of 14 independent
alleles, confirming the studies of others that these represent the two
most prevalent mutations. In addition, we found that three of six het
erozygotes with the T833C allele had post-methionine loading homocyste
ine levels which overlapped with controls and of the other three, one
(as well as an obligate heterozygote who did not carry any of the five
mutant alleles tested) had CBS activity comparable to that of control
s. These findings demonstrate that genotyping is useful as an adjuncti
ve method for the diagnosis of the heterozygous carrier state of CBS d
eficiency.